What are the risks to patients of stem cell transplants?

Stem cell transplantation is a complex process. However, the transplant procedure itself is straightforward, similar in fact to a blood transfusion.

The donor stem cells are transfused through a central line (a catheter) which goes into a major vein in the chest.

The donor stem cells travel through the circulatory system and the stem cells can then start homing to the bone marrow and start dividing and replenishing the immune and blood system.

Chemotherapy and Infection

Once a stem cell transplant has taken place it can take several weeks or months for the donor cells to engraft. Engraftment means the stem cells have started to proliferate (reproduce themselves) within the recipient host.

Before stem cells can be transplanted a patient must undergo high dose chemotherapy. Following transfusion, the patient must be isolated for several weeks or months to avoid infection and to give the donated stem cells a chance to grow and proliferate.

While a patient is waiting for a stem cell transplant to engraft their immune system is severely compromised, because chemotherapy has essentially destroyed it. Therefore, infections before the donated stem cells successfully engraft can be serious and sometimes fatal – this is why patients are kept in isolation for several months, while their body and the donor stem cells grow a corrected, fully functional immune system.

Chemotherapy has significant side effects on the digestive system and sometimes on the body as a whole. Adults cannot withstand the levels of toxicity in chemotherapy that children invariably can and in elderly patients the risk is greater still.

Transplant Failure and GvHD

Failure to engraft, otherwise known as transplant rejection, is another risk. This means the donor recipient’s body has decided the donor stem cells are a threat, rejecting them.

In some cases, transplanted cells and the recipient’s cells can clash in the opposite way, causing what is called “graft versus host disease” (GvHD). This is where the donor cells attack the person who has received the transplant.

GvHD can happen within days of transplants – and up to two years later.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    MILLIONS of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers yesterday revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue

    WideCells Group PLC

    Cord Blood Stem Cells

    Umbilical cord blood stem cells are currently being used to treat more than 80 diseases and disorders, such as leukaemias and aneamias. What are cord blood stem cells? Stem cells found in cord blood are haemopoietic (blood forming). Haemopoietic stem

    WideCells Group PLC

    Why Widecells?

    What’s more important than your health and that of your family? At WideCells we are leading a transformation in stem cell services and stem cell treatment to give you new and better healthcare options. It’s our

    WideCells Group PLC

    What are stems cells?

    It’s estimated that 1 in 3 of us will need a stem cell transplant in our lifetime. What are stem cells? Stem cells are essential for the normal health and functioning of the body, during both development

    WideCells Group PLC

    YOUR BABYCELLS JOURNEY

    Congratulations! No doubt you’re glowing in your pregnancy. With advice and tips coming from all directions, naturally,  as part of your journey you will be wondering how best to protect your family’s future. Your thoughts With

    WideCells Group PLC

    WideCells Group PLC Get Conviction Buy Stance from Align Research

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, has today announced that following the Group’s recent placing, Align Research has released an update note

    WideCells Group PLC

    INTERVIEW: Widecells Group Placing and Looking ahead

    Widecells Group Plc (LON:WDC) CEO João Andrade & CFO David Bridgland talk to DirectorsTalk about the lifting of a trading suspension. João explains why the shares were suspended, if anything was hindered as a result and

    WideCells Group PLC

    Wonder stem cell cure for heart failure

    Millions of heart failure patients could be saved thanks to a new stem cell therapy being tested in Britain. Researchers revealed a breakthrough treatment that cuts out the need for operations by revitalising damaged tissue using

    WideCells Group PLC

    WideCells Group PLC Placing Update and Financial Position

    WideCells Group PLC (LON:WDC) the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, provides the following update on its financial position. As announced on 5 June 2018, the

    WideCells Group PLC

    WideCells Group PLC Audited Preliminary Results

    WideCells Group PLC (LON:WDC), the healthcare services company focused on providing stem cell services and ground-breaking insurance for stem cell treatment, announced today its audited preliminary results for the period ended 31 December 2017. Copies of the

    WideCells Group PLC

    Why do we have blood types?

    More than a century after their discovery, we still don’t really know what blood types are for. Do they really matter? Carl Zimmer investigates. When my parents informed me that my blood type was A+, I

    WideCells Group PLC

    How synthetic DNA could be used as a sensor

    Konstantinos Vavitsas, The University of Queensland Researchers believe that DNA – the molecule that stores information about life – could one day be used as a type of sensor, to record information based on its surroundings. Synthetic